Pirfenidone treatment of idiopathic pulmonary fibrosis
Pirfenidone is the first antifibrotic agent to be approved for the treatment of pulmonary fibrosis. Idiopathic pulmonary fibrosis (IPF) is one of the idiopathic interstitial pneumonias with the worst prognoses; approximately half of patients die within 3–5 years, and the need for an effective treatm...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publishing
2012-04-01
|
| Schriftenreihe: | Therapeutic Advances in Respiratory Disease |
| Online-Zugang: | https://doi.org/10.1177/1753465812436663 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|